Repros Therapeutics

Repros Therapeutics is a biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders. The Company's product candidates include enclomiphene, which is a single isomer of clomiphene citrate, an orally active small molecule compound, and Proellex, which is an orally administered selective blocker of the progesterone receptor in women, for the treatment of uterine fibroids and endometriosis; enclomiphene is for the treatment of secondary hypogonadism in overweight men wishing to restore normal testicular function. The Company's Proellex product candidate for female reproductive health is a chemical entity, which acts as a selective blocker of the progesterone receptor.

TypeSubsidiary
Parent CompanyAllergan
HQHouston, US
Founded1987
Websitereprosrx.com
Repros Therapeutics was founded in 1987 and is headquartered in Houston, US

Viewing summary data as a guest

Sign up for free to see all data

Repros Therapeutics Office Locations

Repros Therapeutics has an office in Houston
Houston, US (HQ)
2408 Timberloch Place, B-7
Show all (1)

Repros Therapeutics Financials and Metrics

Summary Metrics

Founding Date

1987

Total Funding

$29.5 m
In total, Repros Therapeutics had raised $29.5 m. Repros Therapeutics is a subsidiary of Allergan

Repros Therapeutics Revenue

Repros Therapeutics's revenue was reported to be $47 k in FY, 2016 which is a 54.5% decrease from the previous period.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

9.0k9.0k11.0k47.0k

Revenue growth, %

22%(55%)

General and administrative expense

4.8m5.4m5.1m4.6m

R&D expense

23.7m27.1m24.1m12.8m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

2.0k2.0k2.0k1.0k1.0k1.0k17.0k15.0k10.0k7.0k

General and administrative expense

1.2m1.3m1.3m1.2m1.3m1.1m1.1m1.1m997.0k3.8m

R&D expense

7.3m7.5m6.1m7.3m6.5m5.5m3.8m3.2m3.2m2.1m

Operating expense total

8.6m8.7m7.4m8.5m7.8m6.6m4.9m4.3m4.2m5.9m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

75.8m46.6m21.4m8.7m

Accounts Receivable

1.1m

Inventories

189.0k289.0k84.0k

Current Assets

76.0m46.9m21.5m8.8m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

68.0m60.7m53.1m37.9m32.2m26.2m16.0m12.5m10.5m3.2m

Current Assets

68.6m61.0m53.3m38.4m32.6m26.5m16.3m12.8m10.7m4.5m

PP&E

64.0k42.0k11.0k6.0k5.0k4.0k2.0k

Total Assets

71.8m64.3m56.8m38.5m32.6m26.5m16.3m12.8m10.7m5.4m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(27.7m)(32.5m)(29.2m)(17.3m)

Depreciation and Amortization

257.0k43.0k24.0k5.0k

Inventories

Accounts Payable

Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(8.5m)(8.7m)(24.6m)(8.5m)(7.8m)(22.9m)(4.8m)(9.1m)(13.3m)(5.9m)

Depreciation and Amortization

58.0k270.0k21.0k2.0k3.0k4.0k1.0k

Accounts Payable

3.7m2.6m1.2m2.2m1.8m1.6m1.6m1.8m1.7m

Cash From Operating Activities

(7.6m)(22.0m)(20.5m)(5.3m)(8.9m)(12.5m)(4.6m)
Show all financial metrics

Repros Therapeutics Online and Social Media Presence

Embed Graph

Repros Therapeutics Frequently Asked Questions

  • When was Repros Therapeutics founded?

    Repros Therapeutics was founded in 1987.

  • What is Repros Therapeutics revenue?

    Latest Repros Therapeutics annual revenue is $47 k.

  • Who are Repros Therapeutics competitors?

    Competitors of Repros Therapeutics include Organogenesis, Arsanis and Gotham Therapeutics.

  • Where is Repros Therapeutics headquarters?

    Repros Therapeutics headquarters is located at 2408 Timberloch Place, B-7, Houston.

  • Where are Repros Therapeutics offices?

    Repros Therapeutics has an office in Houston.

  • How many offices does Repros Therapeutics have?

    Repros Therapeutics has 1 office.